Drug Research

FDA Tackles Drug Competition to Improve Patient Access

June 27, 2017

Today, the U.S. Food and Drug Administration is taking two new, important steps to increase competition in the market for prescription drugs and facilitate entry of lower-cost alternatives. The agency published a list of off-patent, off-exclusivity branded drugs without approved generics, and also implemented, for the first time, a new policy to expedite the review […]

CISCRP Recognizes WIRB-Copernicus Group’s Support and Donation to Clinical Trial Awareness and Education

June 27, 2017

The Center for Information and Study on Clinical Research Participation (CISCRP) is honored to recognize WIRB-Copernicus Group’s generous support of its Chicago event and donation to its clinical research education and outreach programs.   The Center for Information and Study on Clinical Research Participation (CISCRP), an independent, non-profit organization dedicated to educating patients and the […]

Roche will remain oncology market leader to 2023, in an increasingly fragmented but growing therapy area, says GBI Research

June 27, 2017

None of the products due to enter the oncology market by 2023 are expected to reach the same levels of success as the highest revenue-generating drugs currently in the market – such as Revlimid, Opdivo and Avastin – according to business intelligence provider GBI Research. The company’s latest report states that the oncology landscape is […]

FDA Tackles Drug Competition to Improve Patient Access

June 27, 2017

Today, the U.S. Food and Drug Administration is taking two new, important steps to increase competition in the market for prescription drugs and facilitate entry of lower-cost alternatives. The agency published a list of off-patent, off-exclusivity branded drugs without approved generics, and also implemented, for the first time, a new policy to expedite the review […]

Clarus Re-submits JATENZO NDA Following Positive Results of inTUne Trial

June 27, 2017

NORTHBROOK, Ill – June 26, 2017 — Clarus Therapeutics, Inc., today announced the re-submission of its New Drug Application (NDA) for JATENZO™ (formerly Rextoro™), the Company’s oral testosterone (T) replacement product for the treatment of low testosterone in hypogonadal men, to the U.S. Food and Drug Administration (FDA).  The new submission addresses all points raised […]

BioreclamationIVT and Qualyst Partner to Market Transporter Certified™ Hepatocytes

June 27, 2017

BioreclamationIVT, a leading provider of biospecimens and related services, today announced that it is partnering with Qualyst Transporter Solutions, LLC (Qualyst) to market Transporter Certified™ cryopreserved human hepatocytes.   Transporter Certified is an industry standard that ensures hepatocytes have physiologic transporter function, metabolic competence and appropriate regulatory pathways under conditions Qualyst has defined. In sandwich […]

NanoViricides’ Poster “Novel Nanoviricides® Highly Effective Against Varicella Zoster Virus in Cell Culture” to be Presented Today at the 2017 Annual Meeting of American Society of Virology

June 27, 2017

SHELTON, Conn., June 26, 2017 /PRNewswire/ — NanoViricides, Inc., (NYSE MKT: NNVC) (the “Company”), a pioneer in developing anti-viral nanomedicine drugs, is pleased to announce that its poster entitled “Novel Nanoviricides® Highly Effective Against Varicella Zoster Virus in Cell Culture” will be presented today at the 36th Annual Meeting of the American Society of Virology […]

European biotech meets new company

June 26, 2017

This April Data MATRIX is proud to join the Bavarian biotech cluster and open its’ German office for international clients. Data MATRIX is a qualified provider for software, data management and biostatistics services for clinical trials. It is now introducing to the European market its’ EDC/IWRS and CTMS products, based on the unique approach to […]

Newly Published Nonclinical Data Highlight the Role of Olumacostat Glasaretil in Sebum Inhibition

June 26, 2017

MENLO PARK, Calif., June 26, 2017 (GLOBE NEWSWIRE) — Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions, today announced that findings from nonclinical studies evaluating the mechanism of action for olumacostat glasaretil (formerly DRM01) […]

Catalyst Biosciences Announces Achievement of Stable Normal Factor IX Blood Levels in a Preclinical Subcutaneous Dosing Model

June 26, 2017

SOUTH SAN FRANCISCO, Calif., June 26, 2017 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (Nasdaq:CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced positive preclinical results of CB 2679d/ISU304, its next-generation coagulation Factor IX, in a well-validated preclinical model of hemophilia B. The results demonstrate the attractive pharmacokinetic and […]

Moleculin Announces Significant Discovery with Potential to Treat Pancreatic Cancer

June 21, 2017

HOUSTON, TX–(Marketwired – June 21, 2017) – Moleculin Biotech, Inc., (NASDAQ: MBRX) (“Moleculin” or the “Company”), a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on license agreements with The University of Texas System on behalf of the M.D. Anderson Cancer Center, today announced the discovery of […]

Data MATRIX to kick off DIA 2017 with networking meeting

June 20, 2017

On June 18, 2017, Data MATRIX invites you and your team to join us at our “pre-DIA” get-together at Rock Bottom Brewery. When your booths are all prepared, make sure you start this summer’s major conference by attending our networking event with key industry collaborators. This networking meeting will be joined by the teams from […]

Biostage Announces Positive Preclinical Data of Cellspan™ Esophageal Implant Presented at the International Society for Stem Cell Research 2017 Annual Meeting

June 20, 2017

HOLLISTON, Mass., June 19, 2017 /PRNewswire/ — Biostage Inc., (Nasdaq: BSTG), (“Biostage” or the “Company”), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the esophagus, bronchus and trachea, announced today that it presented positive preclinical data of its proprietary Cellspan™ Esophageal Implant at the International Society for Stem […]

twoXAR Announces Preclinical Proof-of-Concept Data on Type 2 Diabetes Candidate Study demonstrates the power of artificial intelligence-enabled approaches in accelerating early-stage drug discovery for new treatments in type 2 diabetes

June 20, 2017

PALO ALTO, Calif.–(BUSINESS WIRE)–twoXAR, Inc., an artificial intelligence (AI)-driven biopharmaceutical company, today announced that its candidate, TXR-411, has shown promising results in the db/db mouse model of type 2 diabetes (T2DM). TXR-411 is a molecule that twoXAR identified as having a high probability of being effective in treating T2DM. Proof-of-concept studies in the db/db mouse […]

argenx receives second preclinical milestone payment in collaboration with LEO Pharma

June 20, 2017

Breda, the Netherlands / Ghent, Belgium – argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer, today announced the achievement of the second of two preclinical milestones in connection with its collaboration with LEO Pharma.     “Our […]

WIRB-Copernicus Group to Highlight New Patient Recruitment, Behavioral Assessment and Endpoint Analysis Services; Honor CISCRP and Clinical Trial Volunteers at DIA Annual Meeting

June 15, 2017

WIRB-Copernicus Group® (WCG™), the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced that it will be showcasing its newest companies and technologies at the DIA Annual Meeting in Chicago, IL from June 18-22. Three companies joined the WCG family in May – ThreeWire®, MedAvante and ProPhase. ThreeWire […]

Pimodivir Alone or in Combination with Oseltamivir Demonstrated a Significant Reduction in Viral Load in Adults with Influenza A

June 14, 2017

SHANGHAI–(BUSINESS WIRE)–Janssen Pharmaceuticals, Inc. (Janssen) today announced results from the Phase 2b Topaz Trial which demonstrated that treatment with pimodivir (JNJ-63623872) significantly decreased viral load over seven days versus placebo, in adult patients with acute, uncomplicated seasonal influenza A. Patients treated with pimodivir and oseltamivir (OST) also demonstrated a significantly lower viral load compared with […]

Alpine Immune Sciences Announces Presentation of Preclinical Data Showing Potency of Its First-Generation Dual ICOS and CD28 Antagonist vIgDs in an Animal Model

June 14, 2017

SEATTLE–(BUSINESS WIRE)–Alpine Immune Sciences, Inc. (Alpine), a biotechnology company developing a next-generation immune modulation platform, today announced results from a preclinical study evaluating first-generation variant Ig domains (vIgDs™) from the company’s lead program, ALPN-101. These vIgDs consisted of an ICOS ligand-based inhibitory domain engineered to acquire CD28 modulatory properties, creating a potential first-in-class dual ICOS/CD28 […]

Kura Oncology Presents Preliminary Clinical and Preclinical Data for Tipifarnib in the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma

June 14, 2017

LA JOLLA, Calif., June 14, 2017 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (NASDAQ:KURA), a clinical stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that clinical and preclinical data for tipifarnib in the treatment of relapsed or refractory peripheral T-cell lymphoma (PTCL) was presented at the International Conference on Malignant […]

WIRB-Copernicus Group (WCG) Celebrates IBC Review Milestone

June 13, 2017

WIRB-Copernicus IRB Group® announced today that its Institutional Biosafety Committee Services (IBC Services) group has achieved a major milestone in administering 4,000 convened IBC meetings globally. Since 2001, WCG’s IBC Services has been the unrivaled leader in IBC administration. During the past 16 years, WCG IBC Services has administered IBCs for more than 580 institutions, reviewed […]

AALTO Bio Reagents Launches West Nile Virus Native And Recombinant Proteins for Diagnostic Testing

June 12, 2017

New proteins will advance research in testing and treating the West Nile Virus globally. New York, June 5, 2017 — Enterprise Ireland, the Irish government agency for the promotion of international trade by Irish companies, today celebrated the success of client company Aalto Bio Reagents in launching its first-to-market native and recombinant West Nile virus […]

Poxel Presents New Preclinical Imeglimin Data on Improvement in Diastolic Function at the American Diabetes Association Meeting

June 12, 2017

LYON, France–(BUSINESS WIRE)–POXEL SA (Euronext – POXEL – FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes, announced today that new preclinical Imeglimin data showing protective effects for diabetic cardiomyopathy in a rat model of metabolic syndrome was presented in a poster session at the 77th […]

Drug Candidates Developed Using Zymeworks’ Azymetric Platform Nominated for Late-Stage, Preclinical Development by Lilly

June 12, 2017

VANCOUVER, British Columbia–(BUSINESS WIRE)–Zymeworks Inc. (“Zymeworks”), a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation bispecific and multifunctional biotherapeutics, initially focused on the treatment of cancer, today announced that two bispecific immuno-oncology drug candidates have been nominated by Eli Lilly and Company (“Lilly”) for late-stage, preclinical development. The drug candidates were […]

Saudi Arabia Medical Devices Market is estimated to Witness a Remarkable Growth at a CAGR of 9.5% by 2023

June 9, 2017

Market Highlights Market research future published a half-cooked research report on Saudi Arabia Medical Devices market. The Saudi Arabia Medical Devices market is expected to grow at a CAGR of ~9.5% during the period 2017 to 2023. A medical device is any instrument, appliance including any software, biologic or non-biologic material, to be used for […]

Women Healthcare Market has a Potential to grow at a CAGR of 5% by 2023

June 9, 2017

Market Highlights The women healthcare market is growing at an average rate and is expected to show the similar trend during forecast period. With the growing awareness of early diagnosis, advanced treatment and growing novel drugs to treat the women health disorders among the patients and healthcare professionals has supported the growth of the market.  […]

Kidney Stones Market Foreseen to Grow USD 3 billion till 2022

June 9, 2017

Market Highlights The global market for kidney stones is expected to reach USD 3 billion during the period 2016 to 2022 from USD 1.2 billion in 2015. The global kidney stones market has been evaluated as rapidly growing market and expected that the market will reach high growth figures. There has been a tremendous growth […]

Aptevo Therapeutics Highlights Key Features of Its ADAPTIR™ Protein Therapeutic Platform at Two Industry Conferences

June 8, 2017

SEATTLE, June 07, 2017 (GLOBE NEWSWIRE) — Aptevo Therapeutics Inc. (Nasdaq:APVO), a biotechnology company focused on developing novel immuno-oncology and hematology therapeutics, announced today that aspects of its ADAPTIR™ protein therapeutic platform were showcased recently at the Americas Antibody Congress 2017 in San Diego, May 23-24, 2017, and at the 2017 Next Generation Protein Therapeutics […]

Synlogic Meets First Discovery Milestone in Partnership with AbbVie

June 8, 2017

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Synlogic™ has completed the first phase of its ongoing collaboration with AbbVie. During this first discovery phase of the collaboration Synlogic has identified Synthetic Biotic™ leads for the treatment of inflammatory bowel disease (IBD), including Crohn’s Disease and colitis, using the company’s proprietary discovery and development technology platform. Based on the terms of […]

FEEDBACK